Invus portfolio
86 tracked investments, 16 on the map, $3.7B raised across the mapped portfolio.
- DoctolibSecondary Market
- Scholar RockPost-IPO Equity
- Mission LaneSeries A
- Seaport Therapeutics
- Ring Therapeutics
- Mirador TherapeuticsSeries B
- PayhawkSeries B
- Median TechnologiesPost-IPO Equity
- KlaritySeries B
- Olive
- Element ScienceSeries C
- LEXICON PHARMACEUTICALSPost-IPO Equity
- KSQ TherapeuticsSeries C
- Thrive MarketConvertible Note
- Lycia TherapeuticsSeries C
- ElevateBio
Also in the portfolio
- PayJoy
- Brex
- Triana Biomedicines
- ezCater
- VeraDermics
- Abivax
- Bambusa Therapeutics
- TigerConnect
- Vigil Neuroscience
- Crinetics Pharmaceuticals
- AgomAb Therapeutics
- Pretzel Therapeutics
- Gossamer Bio
- MOMA Therapeutics
- LifeMine Therapeutics
- SMG Swiss Marketplace Group
- Amount
- Dorsia
- Asher Bio
- Snagajob
- Seer
- Flare Therapeutics
- Sagimet Biosciences
- Schrödinger
- Averna Therapeutics
- Belliwelli
- KNIME
- Viseon
- Zero Motorcycles
- Edgewise Therapeutics
- Evox Therapeutics
- Noema Pharma
- City Therapeutics
- Pi Health
- Cava Group
- Abata Therapeutics
- Endeavor BioMedicines
- ImCheck Therapeutics
- Engine Biosciences
- Escale
- Bizagi
- Vicore Pharma
- PatientsLikeMe
- Ambrx
- Inventiva Pharma
- HappyVore
- Health Data Analytics Institute
- Opera Solutions
- Black Diamond Therapeutics
- Taysha Gene Therapies
- Cyclerion Therapeutics
- Fusion Pharmaceuticals
- The Curious AI Company
- Kalaris Therapeutics (formerly AlloVir)
- Ikena Oncology
- Generation Bio
- Morphic Therapeutic
- Future Finance
- ITeos Therapeutics
- vTv Therapeutics